Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hepatitis B vaccines. On the threshold

R H Purcell, J L Gerin

American Journal of Clinical Pathology

|July 1, 1978

Summary

This summary is machine-generated.

New experimental hepatitis B vaccines are being evaluated. These unique vaccines are derived from human plasma, showing safety and antigenicity, but require careful assessment due to inherent vaccine risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon.

Journal of viral hepatitis·2008

Same author

The woodchuck model of HDV infection.

Current topics in microbiology and immunology·2006

Same author

Interferon-gamma-associated responses to woodchuck hepatitis virus infection in neonatal woodchucks and virus-infected hepatocytes.

Journal of viral hepatitis·2004

Same author

Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells.

Vaccine·2001

Same author

The woodchuck model of hepatitis B virus infection.

ILAR journal·2001

Same author

Animal models of hepatitis delta virus infection and disease.

ILAR journal·2001

Same journal

Invasive urothelial carcinoma in association with surface low-grade papillary urothelial carcinoma: clinical and pathologic insights from a rare entity.

American journal of clinical pathology·2026

Same journal

CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.

American journal of clinical pathology·2026

Same journal

Comprehensive multicriteria life cycle assessment of biopsy processing in a surgical pathology department.

American journal of clinical pathology·2026

Same journal

Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma.

American journal of clinical pathology·2026

Same journal

Mismatch repair protein "nonclassic expression loss" pattern in colorectal cancer: an important staining pattern that is not well understood.

American journal of clinical pathology·2026

Same journal

Musculoskeletal pain in medical laboratory personnel: a cross-sectional study.

American journal of clinical pathology·2026

See all related articles

Area of Science:

Hepatitis B virus (HBV) research
Vaccine development and immunology

Background:

Hepatitis B virus has not been successfully cultivated in vitro, posing challenges for vaccine production.
Chronic carriers of hepatitis B are a source for viral antigens.

Purpose of the Study:

To evaluate the safety and antigenicity of newly developed experimental hepatitis B vaccines.
To highlight the unique preparation method of these vaccines.

Main Methods:

Purification of viral antigen from the plasma of human chronic carriers.
Preliminary evaluation of experimental hepatitis B vaccines.

Main Results:

Experimental hepatitis B vaccines appear to be safe.
The vaccines demonstrate antigenicity in preliminary evaluations.

Related Experiment Videos

Conclusions:

Experimental hepatitis B vaccines derived from human plasma show promise.
Careful evaluation is necessary due to the potential risks associated with all vaccines.